Drug Trial Radar · NCT05152147
A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers
Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
920
Actual
Start
Dec 2, 2021
Primary completion
Jul 15, 2026
Study completion Sep 30, 2027
Sponsor
- Lead sponsor
- Jazz PharmaceuticalsJazz Pharmaceuticals (JAZZ)
- Sponsor type
- Industry
- Collaborators
- BeOne Medicines LTD; BeOne Pharmaceutical Co., Ltd.
- First posted
- Dec 9, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is being done to find out if zanidatamab, when given with chemotherapy plus or minus tislelizumab, is safe and works better than trastuzumab given with chemotherapy. The patients in this study will have advanced human epidermal growth factor 2 (HER2)-positive stomach and esophageal cancers that are no longer treatable with surgery (unresectable) or chemoradiation, and/or have grown or spread to other parts of the body (metastatic).
Conditions
- Gastric Neoplasms
- Gastroesophageal Adenocarcinoma
- Esophageal Adenocarcinoma
Interventions
ZanidatamabDrug
Administered IV
TislelizumabDrug
Administered IV
TrastuzumabDrug
Administered intravenously (IV)
CapecitabineDrug
Administered orally (PO bid)
OxaliplatinDrug
Administered IV
CisplatinDrug
Administered IV
5-FluorouracilDrug
Administered IV
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-free survival (PFS) by BICRTime frame: Up to 2.5 years
- Overall survivalTime frame: Up to 3.5 years
Locations
227 sites in 33 countries. Site status is shown where the registry gives one.
Hospital de Gastroenterología Dr Bonorino Udaondo
Buenos Aires, Argentina
Instituto de Investigaciones Metabólicas - IDIM
Buenos Aires, Argentina
Hospital Italiano de Buenos Aires
Buenos Aires, Argentina
Fundación Centro de Medicina Nuclear y Molecular ER
Córdoba, Argentina
Centro Médico Privado CEMAIC
Córdoba, Argentina
Centro de Investigación Pergamino S.A.
Pergamino, Argentina
Centro de Investigación Clínica - Clínica Viedma
Viedma, Argentina
Flinders Medical Centre
Bedford Park, Australia
Austin Health
Heidelberg, Australia
Liverpool Hospital
Liverpool, Australia
Fiona Stanley Hospital
Murdoch, Australia
Imelda VZW
Bonheiden, Belgium
Cliniques Universitaires Saint-Luc
Brussels, Belgium
UZ Gent
Ghent, Belgium
UZ Leuven
Leuven, Belgium
CHU de Liège
Liège, Belgium
Centro Integrado de Pesquisa - CIP
Barretos, Brazil
Fundação Pio XII Hospital de Câncer de Barretos
Barretos, Brazil
Cenantron - Centro Avancado de Tratamento Oncologico Ltda
Belo Horizonte, Brazil
Centro de Pesquisas Clínicas/Fundação Doutor Amaral Carvalho
Brasília, Brazil
Instituto Do Câncer Do Ceará ICC
Fortaleza, Brazil
Hospital de Clinicas de Porto Alegre (HCPA) - PPDS
Porto Alegre, Brazil
Irmandade Da Santa Casa de Misericordia de Porto Alegre
Porto Alegre, Brazil
Hospital Nossa Senhora Da Conceição
Porto Alegre, Brazil
Núcleo de Pesquisa Clínica da Rede São Camilo
Santo André, Brazil
Instituto do Cancer do Estado de São Paulo ICESP
São Paulo, Brazil
Instituto de Oncologia de Sorocaba
Sorocaba, Brazil
Princess Margaret Cancer Centre
Toronto, Canada
Centro de Estudios Clínicos SAGA SpA
Providencia, Chile
Sociedad Oncovida S.A
Santiago, Chile
Icegclinic
Santiago, Chile
BIOCINETIC SpA
Santiago, Chile
Sociedad de Investigaciones Medicas Limitada
Temuco, Chile
Centro Internacional de Estudios Clinicos CIEC
Santiago, Region Metropolitan, Chile
Fundación Arturo López Pérez (FALP) - PPDS
Providencia, Santiago Metropolitan, Chile
Beijing Chao-Yang Hospital, Capital Medical University
Beijing, China
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, China
Beijing Cancer Hospital
Beijing, China
Peking University Third Hospital
Beijing, China
Beijing Luhe Hospital, Capital Medical University
Beijing, China
Showing 40 of 227 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.